Source: Modern Retina Opthalmology, May 2025
Kapil Mishra, MD, assistant professor of ophthalmology at the Gavin Herbert Eye Institute, University of California Irvine, discussed an overview of radiation retinopathy and its challenges in treating uveal melanoma. He presented “Radiation Retinopathy: Future Strategies" during the 2025 Retina World Congress annual meeting.
Mishra introduced a unique treatment paradigm in ocular oncology that prioritizes patient survival first, followed by globe preservation, and then vision restoration.
“When we think about treatment for ocular oncology, and specifically uveal melanoma, there’s this paradigm that we follow that we don’t typically consider in the world of ophthalmology, because we’re so isolated in many ways," he said. “With ocular oncology, it’s very similar to the rest of the body in the sense that life trumps all, and then followed by that, there’s globe preservation, and then after that, there is vision. So as long as we’re able to salvage life and salvage globe, then we can focus on vision."